Astellas Pharma
Dedicated to the development of high-quality peer-reviewed publications covering Astellas products that are compliant with applicable regulations and guidance.
Launch date
Employees
Market cap
AUD34.7b
Enterprise valuation
AUD40.7b (Public information from Sep 2024)
Share price
€10.58 YPH.F
Tokyo Japan (HQ)
Corporate Venture Fund: Astellas Venture
No columns specified